Effects of indomethacin test on intracranial pressure and cerebral hemodynamics in patients with refractory intracranial hypertension: A feasibility study

Neurosurgery

Volumn 71, Issue 2, 2012, Pages 245-257

  Godoy, Daniel A ^a   Rabinstein, Alejandro A ^b   Biestro, Alberto ^c   Ainslie, Philip N ^d   Di Napoli, Mario ^e,f  

^a Neurocritical Care Unit Sanatorio Pasteur   (Argentina)

^b MAYO CLINIC   (United States)

^c HOSPITAL DE CLÍNICAS   (Uruguay)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

^f SMDN Center for Cardiovasc Medicine   (Italy)

Author keywords

Cerebral perfusion pressure; Indomethacin; Intracerebral hemorrhage; Intracranial hypertension; Traumatic brain injury

Indexed keywords

INDOMETACIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN PERFUSION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; GLASGOW OUTCOME SCALE; HEMODYNAMIC MONITORING; HUMAN; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; MALE; PRIORITY JOURNAL; SURVIVAL;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR AGENTS; CEREBROVASCULAR CIRCULATION; CHRONIC DISEASE; FEASIBILITY STUDIES; FEMALE; HUMANS; INDOMETHACIN; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; MALE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84864277371     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e318256b9f5     Document Type: Article

References (54)

1. Miller JD, Becker DP, Ward JD, Sullivan HG, Adams WE, Rosner MJ. Significance of intracranial hypertension in severe head injury. J Neurosurg. 1977; 47(4):503-516.
2. Rangel-Castilla L, Gopinath S, Robertson CS. Management of intracranial hypertension. Neurol Clin. 2008;26(2):521-541, x.
3. Marshall LF, Smith RW, Shapiro HM. The outcome with aggressive treatment in severe head injuries. Part I: the significance of intracranial pressure monitoring. J Neurosurg. 1979;50(1):20-25.
4. Meyer MJ, Megyesi J, Meythaler J, et al. Acute management of acquired brain injury part I: an evidence-based review of non-pharmacological interventions. Brain Inj. 2010;24(5):694-705.
5. Meyer MJ, Megyesi J, Meythaler J, et al. Acute management of acquired brain injury part II: an evidence-based review of pharmacological interventions. Brain Inj. 2010;24(5):706-721.
6. Slavik RS, Rhoney DH. Indomethacin: a review of its cerebral blood flow effects and potential use for controlling intracranial pressure in traumatic brain injury patients. Neurol Res. 1999;21(5):491-499.
7. Roberts RG, Redman JW. Indomethacin-a review of its role in the management of traumatic brain injury. Crit Care Resusc. 2002;4(4):271-280.
8. Rasmussen M. Treatment of elevated intracranial pressure with indomethacin: friend or foe? Acta Anaesthesiol Scand. 2005;49(3):341-350.
9. Dahl B, Bergholt B, Cold GE, et al. CO(2) and indomethacin vasoreactivity in patients with head injury. Acta Neurochir (Wien). 1996;138(3):265-273.
10. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2(7872):81-84.
11. Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32(4):891-897.
12. Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996;27(8):1304-1305.
13. Marshall LF, Marshall SB, Klauber MR, et al. A new classification of head injury based on computerized tomography. J Neurosurg. 1991;75(1S):S14-S20.
14. Cruz J. Combined continuous monitoring of systemic and cerebral oxygenation in acute brain injury: preliminary observations. Crit Care Med. 1993;21(8): 1225-1232.
15. Cruz J. Relationship between early patterns of cerebral extraction of oxygen and outcome from severe acute traumatic brain swelling: cerebral ischemia or cerebral viability? Crit Care Med. 1996;24(6):953-956.
16. Cruz J, Nakayama P, Imamura JH, Rosenfeld KG, de Souza HS, Giorgetti GV. Cerebral extraction of oxygen and intracranial hypertension in severe, acute, pediatric brain trauma: preliminary novel management strategies. Neurosurgery. 2002;50(4):774-779; discussion 779-780.
17. Obrist WD, Langfitt TW, Jaggi JL, Cruz J, Gennarelli TA. Cerebral blood flow and metabolism in comatose patients with acute head injury. Relationship to intracranial hypertension. J Neurosurg. 1984;61(2):241-253.
18. Poca MA, Sahuquillo J, Vilalta A, Garnacho A. Lack of utility of arteriojugular venous differences of lactate as a reliable indicator of increased brain anaerobic metabolism in traumatic brain injury. J Neurosurg. 2007;106(4):530-537.
19. Valadka AB, Furuya Y, Hlatky R, Robertson CS. Global and regional techniques for monitoring cerebral oxidative metabolism after severe traumatic brain injury. Neurosurg Focus. 2000;9(5):e3.
20. Bullock MR, Chesnut R, Ghajar J, et al. Surgical management of traumatic parenchymal lesions. Neurosurgery. 2006;58(3 suppl):S25-S46; discussion Si-Siv.
21. Morgenstern LB, Hemphill JC III, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41(9):2108-2129.
22. Jensen K, Freundlich M, Bunemann L, Therkelsen K, Hansen H, Cold GE. The effect of indomethacin upon cerebral blood flow in healthy volunteers. The influence of moderate hypoxia and hypercapnia. Acta Neurochir (Wien). 1993;124 (2-4):114-119.
23. Biestro AA, Alberti RA, Soca AE, Cancela M, Puppo CB, Borovich B. Use of indomethacin in brain-injured patients with cerebral perfusion pressure impairment: preliminary report. J Neurosurg. 1995;83(4):627-630.
24. Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma. 1998;15(8):573-585.
25. Bullock MR, Povlishock JT. Guidelines for the management of severe traumatic brain injury. J Neurotrauma. 2007;24(suppl 1):S1-S106.
26. Cooper DJ, Rosenfeld JV, Murray L, et al. Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med. 2011;364(16):1493-1502.
27. Stocchetti N, Maas AI, Chieregato A, van der Plas AA. Hyperventilation in head injury: a review. Chest. 2005;127(5):1812-1827.
28. Fox JL, Vu EN, Doyle-Waters M, Brubacher JR, Abu-Laban R, Hu Z. Prophylactic hypothermia for traumatic brain injury: a quantitative systematic review. CJEM. 2010;12(4):355-364.
29. Clifton GL, Valadka A, Zygun D, et al. Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial. Lancet Neurol. 2011;10(2):131-139.
30. Rasmussen M, Tankisi A, Cold GE. The effects of indomethacin on intracranial pressure and cerebral haemodynamics in patients undergoing craniotomy: a randomised prospective study. Anaesthesia. 2004;59(3):229-236.
31. Eriksson S, Hagenfeldt L, Law D, Patrono C, Pinca E, Wennmalm A. Effect of prostaglandin synthesis inhibitors on basal and carbon dioxide stimulated cerebral blood flow in man. Acta Physiol Scand. 1983;117(2):203-211.
32. Pickard J, Tamura A, Stewart M, McGeorge A, Fitch W. Prostacyclin, indomethacin and the cerebral circulation. Brain Res. 1980;197(2):425-431.
33. Pickard JD, MacDonell LA, Mackenzie ET, Harper AM. Prostaglandininduced effects in the primate cerebral circulation. Eur J Pharmacol. 1977;43 (4):343-351.
34. Quintana A, Raczka E, Quintana MA. Effects of indomethacin and diclofenac on cerebral blood flow in hypercapnic conscious rats. Eur J Pharmacol. 1988;149(3): 385-388.
35. Markus HS, Vallance P, Brown MM. Differential effect of three cyclooxygenase inhibitors on human cerebral blood flow velocity and carbon dioxide reactivity. Stroke. 1994;25(9):1760-1764.
36. Harrigan MR, Tuteja S, Neudeck BL. Indomethacin in the management of elevated intracranial pressure: a review. J Neurotrauma. 1997;14(9):637-650.
37. Upton RN, Rasmussen M, Grant C, Martinez AM, Cold GE, Ludbrook GL. Pharmacokinetics and pharmacodynamics of indomethacin: effects on cerebral blood flow in anaesthetized sheep. Clin Exp Pharmacol Physiol. 2008;35(3): 317-323.
38. Jensen K, Ohrstrom J, Cold GE, Astrup J. The effects of indomethacin on intracranial pressure, cerebral blood flow and cerebral metabolism in patients with severe head injury and intracranial hypertension. Acta Neurochir (Wien). 1991;108 (3-4):116-121.
39. Weigert G, Berisha F, Resch H, Karl K, Schmetterer L, Garhofer G. Effect of unspecific inhibition of cyclooxygenase by indomethacin on retinal and choroidal blood flow. Invest Ophthalmol Vis Sci. 2008;49(3):1065-1070.
40. Jensen K, Kjaergaard S, Malte E, Bunemann L, Therkelsen K, Knudsen F. Effect of graduated intravenous and standard rectal doses of indomethacin on cerebral blood flow in healthy volunteers. J Neurosurg Anesthesiol. 1996;8(2): 111-116.
41. Imberti R, Fuardo M, Bellinzona G, Pagani M, Langer M. The use of indomethacin in the treatment of plateau waves: effects on cerebral perfusion and oxygenation. J Neurosurg. 2005;102(3):455-459.
42. Burgess KR, Fan JL, Peebles K, et al. Exacerbation of obstructive sleep apnea by oral indomethacin. Chest. 2010;137(3):707-710.
43. Clemmesen JO, Hansen BA, Larsen FS. Indomethacin normalizes intracranial pressure in acute liver failure: a twenty-three-year-old woman treated with indomethacin. Hepatology. 1997;26(6):1423-1425.
44. Czosnyka M, Richards HK, Whitehouse HE, Pickard JD. Relationship between transcranial Doppler-determined pulsatility index and cerebrovascular resistance: an experimental study. J Neurosurg. 1996;84(1):79-84.
45. Sorrentino E, Budohoski KP, Kasprowicz M, et al. Critical thresholds for transcranial Doppler Indices of cerebral autoregulation in traumatic brain injury. Neurocrit Care. 2011;14(10):188-193.
46. ter Minassian A, Melon E, Leguerinel C, Lodi CA, Bonnet F, Beydon L. Changes in cerebral blood flow during PaCO2 variations in patients with severe closed head injury: comparison between the Fick and transcranial Doppler methods. J Neurosurg. 1998;88(6):996-1001.
47. Valdueza JM, Balzer JO, Villringer A, Vogl TJ, Kutter R, Einhaupl KM. Changes in blood flow velocity and diameter of the middle cerebral artery during hyperventilation: assessment with MR and transcranial Doppler sonography. AJNR Am J Neuroradiol. 1997;18(10):1929-1934.
48. Puppo C, Lopez L, Farina G, et al. Indomethacin and cerebral autoregulation in severe head injured patients: a transcranial Doppler study. Acta Neurochir (Wien). 2007;149(2):139-149; discussion 149.
49. Godoy DA, Biestro A, Puppo C. Does indomethacin cause cerebral ischemia? Acta Anaesthesiol Scand. 2005;49(10):1577-1578.
50. Rasmussen M, Ostergaard L, Juul N, Gyldensted C, Poulsen PV, Cold GE. Do indomethacin and propofol cause cerebral ischemic damage? Diffusion-weighted magnetic resonance imaging in patients undergoing craniotomy for brain tumors. Anesthesiology. 2004;101(4):872-878.
51. Schumann P, Touzani O, Young AR, Verard L, Morello R, MacKenzie ET. Effects of indomethacin on cerebral blood flow and oxygen metabolism: a positron emission tomographic investigation in the anaesthetized baboon. Neurosci Lett. 1996;220(2):137-141.
52. Steiner LA, Andrews PJ. Monitoring the injured brain: ICP and CBF. Br J Anaesth. 2006;97(1):26-38.
53. Tofteng F, Larsen FS. The effect of indomethacin on intracranial pressure, cerebral perfusion and extracellular lactate and glutamate concentrations in patients with fulminant hepatic failure. J Cereb Blood Flow Metab. 2004;24(7): 798-804.
54. Kamel H, Navi BB, Nakagawa K, Hemphill JC 3rd, Ko NU. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med. 2011;39(3):554-559.